1. Sub-Segment: Continuous Flow Centrifugal Blood Pumps
Continuous flow centrifugal blood pumps are expected to witness significant growth in the market. These pumps provide continuous blood flow, thereby offering improved hemodynamic stability and reduced likelihood of complications during cardiac surgeries. The continuous flow centrifugal blood pumps segment is further expected to be driven by factors such as their compact size, ease of use, and ability to deliver precise flow rates. Additionally, these pumps have shown promising outcomes in patients with end-stage heart failure, further propelling their demand in the market.
The centrifugal blood pumps market is highly competitive and characterized by the presence of several key players. Some of the prominent market players include:
1. Medtronic
2. Terumo Corporation
3. Abbott Laboratories
4. Getinge AB
5. LivaNova PLC
6. Fresenius Medical Care AG & Co. KGaA
7. Abiomed Inc.
8. BiVACOR Inc.
9. ELITechGroup
10. Calon Cardio-Technology Ltd.
These companies are focusing on strategic collaborations, mergers and acquisitions, and research and development activities to strengthen their market position. They are also investing in technological advancements to develop innovative centrifugal blood pumps and expand their product offerings. The competitive landscape of the centrifugal blood pumps market is expected to witness intense competition and further technological advancements in the coming years.